Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Tracking oxygen in the body
MRI sensor that enables long-term monitoring of oxygen levels could aid cancer diagnosis and treatment.
Targeting cancer with a triple threat
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Precision attack on cancer
Michael Hemann seeks better ways to deploy chemotherapy drugs and overcome tumor resistance.
How tumors escape
Biologists identify extracellular proteins that help aggressive tumors spread through the body.
Resistance is futile
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
Military medicine
Senior Laura Lu’s years at MIT have included cancer research, ROTC leadership, and prosthesis trials — and she aims to put her talents to use one day as a Navy surgeon.
Keeping an eye on bird flu
MIT studies of two influenza viruses reveal genetic mutations that could result in pandemic flu.
Angela Belcher wins $500,000 Lemelson-MIT Prize
MIT professor honored for her innovations that take cues, and materials, from nature to tackle key societal issues.
Potential flu pandemic lurks
MIT study identifies influenza viruses circulating in pigs and birds that could pose a risk to humans.